Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
878.8 INR | -1.03% | +3.63% | -3.42% |
Sales 2024 * | 19.71B 236M | Sales 2025 * | 26.49B 317M | Capitalization | 121B 1.45B |
---|---|---|---|---|---|
Net income 2024 * | 4.1B 49.07M | Net income 2025 * | 4.38B 52.45M | EV / Sales 2024 * | 6.66 x |
Net Debt 2024 * | 10.44B 125M | Net Debt 2025 * | 11.22B 134M | EV / Sales 2025 * | 4.98 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
27.3
x | Employees | 3,548 |
Yield 2024 * |
0.76% | Yield 2025 * |
0.77% | Free-Float | 24.65% |
Latest transcript on Eris Lifesciences Limited
1 day | -1.03% | ||
1 week | +3.63% | ||
Current month | -1.91% | ||
1 month | +1.35% | ||
3 months | -1.10% | ||
6 months | -3.12% | ||
Current year | -3.42% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-01-26 | |
Vijay S. Joshi
PSD | President | - | 10-04-30 |
Sachin Shah
DFI | Director of Finance/CFO | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kalpana Unadkat
BRD | Director/Board Member | 53 | 21-01-04 |
Prashant Gupta
BRD | Director/Board Member | 44 | 18-04-29 |
Chief Executive Officer | 50 | 07-01-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 112 M€ | +5.68% | - | |
0.00% | 7 M€ | +6.66% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 878.8 | -1.03% | 63 784 |
24-05-15 | 888 | +1.38% | 538,717 |
24-05-14 | 876 | +3.05% | 48,420 |
24-05-13 | 850 | -0.72% | 63,727 |
24-05-10 | 856.2 | +0.96% | 21,501 |
Delayed Quote NSE India S.E., May 16, 2024 at 05:11 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.42% | 1.45B | |
+35.01% | 709B | |
+30.71% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.13% | 239B | |
+9.31% | 211B | |
-3.35% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- ERIS Stock